Koyfin Home > Directory > Health Care > Adamas Pharma > Price / Earnings (ntm)

Adamas Pharma Price / Earnings (ntm) Chart (ADMS)

Adamas Pharma annual/quarterly Price / Earnings (ntm) from 2014 to 2014. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Adamas Pharma Price / Earnings (ntm) for the quarter ending May 05, 2014 was 46.12 a 39.06% increase of 18.02 year over year
  • Adamas Pharma Price / Earnings (ntm) for the last 12 months ending May 05, 2014 was 46.12 a 39.06% increase of 18.02 year over year
  • Adamas Pharma Annual Price / Earnings (ntm) for 2014 was 46.12 a 39.76% increase of 18.34 from 2013
  • Adamas Pharma Annual Price / Earnings (ntm) for 2014 was 27.78 a -0.42% decrease of -0.12 from 2013
  • Adamas Pharma Annual Price / Earnings (ntm) for 2014 was 27.90 a -0.73% decrease of -0.20 from 2013
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS Price / Earnings (ntm) Data

05/201446.12
05/201427.78
05/201427.90
05/201428.10
05/201428.96
05/201429.02
05/201429.02

Annual ADMS Price / Earnings (ntm) Data

201446.12
201427.78
201427.90
201428.10
201428.96
201429.02
201429.02